registrieren | anmelden | FAQ      [?] 

Tag anti-tnf [23 articles]

Recent papers classified by the tag anti-tnf.
  • Certolizumab pegol for the treatment of Crohn's disease.
    The New England journal of medicine, Vol. 357, No. 3. (19 July 2007), pp. 228-238.
    by WJ Sandborn, BG Feagan, S Stoinov, PJ Honiball, P Rutgeerts, D Mason, R Bloomfield, S Schreiber,
    posted to ibd anti-tnf by djmonstermo on 2008-07-20 02:15:42 as **
  • Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.
    JAMA : the journal of the American Medical Association, Vol. 295, No. 19. (17 May 2006), pp. 2275-2285.
    by T Bongartz, AJ Sutton, MJ Sweeting, I Buchan, EL Matteson, V Montori
    posted to anti-tnf by djmonstermo on 2008-07-18 04:06:04 as **
  • Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.
    Lancet, Vol. 356, No. 9227. (29 July 2000), pp. 385-390.
    by PJ Mease, BS Goffe, J Metz, A VanderStoep, B Finck, DJ Burge
    posted to rheum anti-tnf by djmonstermo on 2008-07-20 04:50:23 as **
  • A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.
    The New England journal of medicine, Vol. 343, No. 22. (30 November 2000), pp. 1586-1593.
    by JM Bathon, RW Martin, RM Fleischmann, JR Tesser, MH Schiff, EC Keystone, MC Genovese, MC Wasko, LW Moreland, AL Weaver, J Markenson, BK Finck
    posted to rheum anti-tnf by djmonstermo on 2008-07-20 04:48:50 as **
  • Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.
    The New England journal of medicine, Vol. 342, No. 11. (16 March 2000), pp. 763-769.
    by DJ Lovell, EH Giannini, A Reiff, GD Cawkwell, ED Silverman, JJ Nocton, LD Stein, A Gedalia, NT Ilowite, CA Wallace, J Whitmore, BK Finck
    posted to rheum anti-tnf by djmonstermo on 2008-07-20 04:47:52 as **
  • Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
    Annals of internal medicine, Vol. 130, No. 6. (16 March 1999), pp. 478-486.
    by LW Moreland, MH Schiff, SW Baumgartner, EA Tindall, RM Fleischmann, KJ Bulpitt, AL Weaver, EC Keystone, DE Furst, PJ Mease, EM Ruderman, DA Horwitz, DG Arkfeld, L Garrison, DJ Burge, CM Blosch, ML Lange, ND McDonnell, ME Weinblatt
    posted to rheum anti-tnf by djmonstermo on 2008-07-20 04:46:49 as **
  • A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
    The New England journal of medicine, Vol. 340, No. 4. (28 January 1999), pp. 253-259.
    by ME Weinblatt, JM Kremer, AD Bankhurst, KJ Bulpitt, RM Fleischmann, RI Fox, CG Jackson, M Lange, DJ Burge
    posted to rheum anti-tnf by djmonstermo on 2008-07-20 04:44:57 as **
  • Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.
    The New England journal of medicine, Vol. 348, No. 7. (13 February 2003), pp. 601-608.
    by F Baert, M Noman, S Vermeire, G Van Assche, G D' Haens, A Carbonez, P Rutgeerts
    posted to ibd anti-tnf by djmonstermo on 2008-07-11 18:12:37 as **
  • Infliximab for induction and maintenance therapy for ulcerative colitis.
    The New England journal of medicine, Vol. 353, No. 23. (8 December 2005), pp. 2462-2476.
    by P Rutgeerts, WJ Sandborn, BG Feagan, W Reinisch, A Olson, J Johanns, S Travers, D Rachmilewitz, SB Hanauer, GR Lichtenstein, WJ de Villiers, D Present, BE Sands, JF Colombel
    posted to ibd anti-tnf by djmonstermo on 2008-07-11 18:49:27 as **
  • Infliximab for the treatment of fistulas in patients with Crohn's disease.
    The New England journal of medicine, Vol. 340, No. 18. (6 May 1999), pp. 1398-1405.
    by DH Present, P Rutgeerts, S Targan, SB Hanauer, L Mayer, RA van Hogezand, DK Podolsky, BE Sands, T Braakman, KL DeWoody, TF Schaible, SJ van Deventer
    posted to ibd anti-tnf by djmonstermo on 2008-07-11 18:11:23 as **
  • A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
    The New England journal of medicine, Vol. 337, No. 15. (9 October 1997), pp. 1029-1035.
    by SR Targan, SB Hanauer, SJ van Deventer, L Mayer, DH Present, T Braakman, KL DeWoody, TF Schaible, PJ Rutgeerts
    posted to ibd anti-tnf by djmonstermo on 2008-07-11 18:11:03 as **
  • Infliximab for the treatment of rheumatoid arthritis.
    Cochrane database of systematic reviews (Online), No. 3. (2002)
    by B Blumenauer, M Judd, G Wells, A Burls, A Cranney, M Hochberg, P Tugwell
    posted to rheum anti-tnf by djmonstermo on 2008-07-20 04:56:59 as **
  • Etanercept for the treatment of rheumatoid arthritis.
    Cochrane database of systematic reviews (Online), No. 4. (2003)
    by B Blumenauer, M Judd, A Cranney, A Burls, D Coyle, M Hochberg, P Tugwell, G Wells
    posted to rheum anti-tnf by djmonstermo on 2008-07-20 04:56:40 as **
  • Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 39, No. 3. (1 August 2004), pp. 295-299.
    by AK Mohan, TR Coté, JA Block, AM Manadan, JN Siegel, MM Braun
    posted to anti-tnf by djmonstermo on 2008-07-20 04:55:33 as **
  • Drug-induced systemic lupus erythematosus associated with etanercept therapy.
    Lancet, Vol. 359, No. 9306. (16 February 2002), pp. 579-580.
    by N Shakoor, M Michalska, CA Harris, JA Block
    posted to anti-tnf by djmonstermo on 2008-07-20 04:55:13 as **
  • Autoimmune skin rashes associated with etanercept for rheumatoid arthritis.
    Annals of internal medicine, Vol. 131, No. 8. (19 October 1999)
    by PH Brion, A Mittal-Henkle, KC Kalunian
    posted to anti-tnf by djmonstermo on 2008-07-20 04:54:54 as **
  • Maintenance therapy with certolizumab pegol for Crohn's disease.
    The New England journal of medicine, Vol. 357, No. 3. (19 July 2007), pp. 239-250.
    by S Schreiber, M Khaliq-Kareemi, IC Lawrance, OØ Thomsen, SB Hanauer, J McColm, R Bloomfield, WJ Sandborn,
    posted to ibd anti-tnf by djmonstermo on 2008-07-20 02:16:36 as **
  • Etanercept as monotherapy in patients with psoriasis.
    The New England journal of medicine, Vol. 349, No. 21. (20 November 2003), pp. 2014-2022.
    by CL Leonardi, JL Powers, RT Matheson, BS Goffe, R Zitnik, A Wang, AB Gottlieb,
    posted to rheum anti-tnf by djmonstermo on 2008-07-20 04:52:26 as **
  • Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
    The New England journal of medicine, Vol. 346, No. 18. (2 May 2002), pp. 1349-1356.
    by JD Gorman, KE Sack, JC Davis
    posted to rheum anti-tnf by djmonstermo on 2008-07-20 04:51:59 as **
  • Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.
    Lancet, Vol. 354, No. 9194. (4 December 1999), pp. 1932-1939.
    by R Maini, EW St Clair, F Breedveld, D Furst, J Kalden, M Weisman, J Smolen, P Emery, G Harriman, M Feldmann, P Lipsky
    posted to rheum anti-tnf by djmonstermo on 2008-07-18 03:39:12 as **
  • Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
    Lancet, Vol. 359, No. 9317. (4 May 2002), pp. 1541-1549.
    by SB Hanauer, BG Feagan, GR Lichtenstein, LF Mayer, S Schreiber, JF Colombel, D Rachmilewitz, DC Wolf, A Olson, W Bao, P Rutgeerts,
    posted to ibd anti-tnf by djmonstermo on 2008-07-18 03:35:18 as **
  • Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
    The New England journal of medicine, Vol. 343, No. 22. (30 November 2000), pp. 1594-1602.
    by PE Lipsky, DM van der Heijde, EW St Clair, DE Furst, FC Breedveld, JR Kalden, JS Smolen, M Weisman, P Emery, M Feldmann, GR Harriman, RN Maini,
    posted to rheum anti-tnf by djmonstermo on 2008-07-18 03:32:49 as **
  • Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.
    N Engl J Med, Vol. 345, No. 15. (11 October 2001), pp. 1098-1104.
    by J Keane, S Gershon, RP Wise, E Mirabile-Levens, J Kasznica, WD Schwieterman, JN Siegel, MM Braun
    posted to anti-tnf by djmonstermo on 2008-07-18 03:29:07 as ** along with 1 person jjray
    • Bemerkung: Sie können diese Seite wie folgt zitieren: http://www.citeulike.org/tag/anti-tnf

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.